Stockholders' Equity (Tables)

12 Months Ended

Sep. 30, 2018

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense is recorded in general and administrative expenses and is presented below for the years ended September 30, 2018 and 2017:

	2018		2017
Stock Grants	$	287,000	$	241,000
Restricted Stock Grants		55,000		52,000
Option Grants		17,000		50,000
Employee Stock Purchase Plan		3,000		3,000
Subsidiary Option Grants		95,000		110,000
Total	$	457,000	$	456,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the years ended September 30, 2018 and 2017 is presented below:

Restricted Stock Activity for the Year ended September 30, 2018	Shares			Weighted-Average  Grant-Date Fair Value
Nonvested at September 30, 2017		70,000		$	1.73
Granted		20,000		$	1.37
Vested		(30,000	)	$	1.73
Cancelled		-			-
Nonvested and expected to vest at September 30, 2018		60,000		$	1.61

Restricted Stock Activity for the Year ended  September 30, 2017	Shares			Weighted-Average  Grant-Date Fair Value
Nonvested at September 30, 2016		100,000		$	1.73
Granted		-			-
Vested		(30,000	)	$	1.73
Cancelled		-			-
Nonvested and expected to vest at September 30, 2017		70,000		$	1.73

Share-based Compensation, Stock Options, Activity [Table Text Block]

Stock options outstanding at September 30, 2018 are described as follows:

Outstanding Stock Options at September 30, 2018
Range of  Exercise  Prices		Options  Outstanding		Weighted Average Contractual Life (years)		Weighted Average Exercise Price		Options  Exercisable		Weighted  Average  Exercise  Price
$	1.80 - 1.99		95,602		1.34	$	1.80		95,602	$	1.80
	2.00 - 2.33		64,935		0.34		2.33		64,935		2.33
$	1.80 - 2.33		160,537		0.93	$	2.01		160,537	$	2.01

Stock Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of stock option activity for the years ended September 30, 2018 and 2017 is presented below:

	Options  Outstanding			Weighted Average  Exercise Price per Share ($)		Weighted Average  Remaining  Contractual Term (in Years)
Balance at September 30, 2016		123,147			2.30		1.69
Outstanding and exercisable at September 30, 2016		123,147			2.30		1.69
Granted		95,602			1.80
Exercised		-			-
Cancelled		(21,980	)		3.03
Balance at September 30, 2017		196,769			1.98		1.64
Outstanding and exercisable at September 30, 2017		196,769			1.98		1.64
Granted		-			-
Exercised		-			-
Cancelled		(36,232	)		1.82
Balance at September 30, 2018		160,537			2.01		0.93
Outstanding and exercisable at September 30, 2018		160,537			2.01		0.93

Subsidiary Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of Xcede stock option activity for the years ended September 30, 2018 and 2017 is presented below:

	Options  Outstanding			Weighted Average Exercise Price per  Share ($)		Weighted Average  Remaining  Contractual Term  (in Years)
Balance, expected to vest, at September 30, 2016		613,653			1.00		8.35
Outstanding and exercisable at September 30, 2016		320,586			1.00		8.01
Granted		810,500			1.00
Exercised		-			-
Cancelled		(48,197	)		1.00
Balance, expected to vest, at September 30, 2017		1,375,956			1.00		8.70
Outstanding and exercisable at September 30, 2017		923,617			1.00		8.30
Granted		-			-
Exercised		-			-
Cancelled		(75,000	)		1.00
Balance, expected to vest, at September 30, 2018		1,300,956			1.00		7.31
Outstanding and exercisable at September 30, 2018		1,229,685			1.00		7.11